These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 34484446)

  • 1. Fatal rapidly progressive interstitial lung disease in a patient with amyopathic dermatomyositis.
    Mobeireek A; Conca W; Mohammed S; AlObaid F; AlHajji M
    Ann Thorac Med; 2021; 16(3):294-298. PubMed ID: 34484446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A systematic review of adult-onset clinically amyopathic dermatomyositis (dermatomyositis siné myositis): a missing link within the spectrum of the idiopathic inflammatory myopathies.
    Gerami P; Schope JM; McDonald L; Walling HW; Sontheimer RD
    J Am Acad Dermatol; 2006 Apr; 54(4):597-613. PubMed ID: 16546580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-Melanoma Differentiation-Associated Gene 5 Is Associated With Rapidly Progressive Lung Disease and Poor Survival in US Patients With Amyopathic and Myopathic Dermatomyositis.
    Moghadam-Kia S; Oddis CV; Sato S; Kuwana M; Aggarwal R
    Arthritis Care Res (Hoboken); 2016 May; 68(5):689-94. PubMed ID: 26414240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-MDA5-associated dermatomyositis.
    Gupta R; Kumar S; Gow P; Hsien-Cheng Chang L; Yen L
    Intern Med J; 2020 Apr; 50(4):484-487. PubMed ID: 32270621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myofascia-dominant involvement on whole-body MRI as a risk factor for rapidly progressive interstitial lung disease in dermatomyositis.
    Karino K; Kono M; Kono M; Sakamoto K; Fujieda Y; Kato M; Amengual O; Oku K; Yasuda S; Atsumi T
    Rheumatology (Oxford); 2020 Jul; 59(7):1734-1742. PubMed ID: 31925431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adult clinically amyopathic dermatomyositis with rapid progressive interstitial lung disease: a retrospective cohort study.
    Ye S; Chen XX; Lu XY; Wu MF; Deng Y; Huang WQ; Guo Q; Yang CD; Gu YY; Bao CD; Chen SL
    Clin Rheumatol; 2007 Oct; 26(10):1647-54. PubMed ID: 17308858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19 or clinical amyopathic dermatomyositis associated rapidly progressive interstitial lung disease? A case report.
    Cao M; Zhang S; Chu D; Xiao M; Liu X; Yu L; Li J; Huang Y; Fang F
    BMC Pulm Med; 2020 Nov; 20(1):304. PubMed ID: 33213393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapidly Progressive Interstitial Lung Disease With Pneumothorax and Pneumomediastinum Secondary to Amyopathic Dermatomyositis.
    Imzil A; Assoufi N; Mouline S; El Kharras A; Naji-Amrani H
    Cureus; 2023 Dec; 15(12):e50780. PubMed ID: 38239536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomarkers and Autoantibodies of Interstitial Lung Disease with Idiopathic Inflammatory Myopathies.
    Yoshifuji H
    Clin Med Insights Circ Respir Pulm Med; 2015; 9(Suppl 1):141-6. PubMed ID: 27081322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple values of
    Li Y; Zhou Y; Wang Q
    Clin Rheumatol; 2017 Oct; 36(10):2297-2305. PubMed ID: 28831580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypomyopathic dermatomyositis associated with interstitial lung disease and good response to mycophenolate mofetil: case-based review.
    Koyama RVL; Braga TKK; da Silva Dias GA; Fujihara S; Fuzii HT; Yoshikawa GT
    Clin Rheumatol; 2017 Aug; 36(8):1919-1926. PubMed ID: 28488124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence and impact of interstitial lung disease and malignancy in patients with polymyositis, dermatomyositis, and clinically amyopathic dermatomyositis: a retrospective cohort study.
    Ikeda S; Arita M; Misaki K; Mishima S; Takaiwa T; Nishiyama A; Ito A; Furuta K; Yokoyama T; Tokioka F; Noyama M; Yoshioka H; Ishida T
    Springerplus; 2015; 4():240. PubMed ID: 26101728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case of Amyopathic Dermatomyositis associated with Interstitial Pulmonary Disease.
    Ugan Y; Sahin M; Dogru A; Bayram D; Ceyhan AM; Tunc SE
    Clin Ter; 2015; 166(6):253-5. PubMed ID: 26794813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of anti-MDA5 antibody as a diagnostic biomarker in patients with dermatomyositis-associated interstitial lung disease or rapidly progressive interstitial lung disease.
    Li L; Wang Q; Wen X; Liu C; Wu C; Yang F; Zeng X; Li Y
    Oncotarget; 2017 Sep; 8(44):76129-76140. PubMed ID: 29100298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapidly progressive interstitial lung disease due to anti-MDA5 antibodies without skin involvement: a case report and literature review.
    González-Moreno J; Raya-Cruz M; Losada-Lopez I; Cacheda AP; Oliver C; Colom B
    Rheumatol Int; 2018 Jul; 38(7):1293-1296. PubMed ID: 29417209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical differences between interstitial lung disease associated with clinically amyopathic dermatomyositis and classic dermatomyositis.
    Mukae H; Ishimoto H; Sakamoto N; Hara S; Kakugawa T; Nakayama S; Ishimatsu Y; Kawakami A; Eguchi K; Kohno S
    Chest; 2009 Nov; 136(5):1341-1347. PubMed ID: 19581351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of Mortality in Autoimmune Myositis With and Without Associated Interstitial Lung Disease.
    Johnson C; Pinal-Fernandez I; Parikh R; Paik J; Albayda J; Mammen AL; Christopher-Stine L; Danoff S
    Lung; 2016 Oct; 194(5):733-7. PubMed ID: 27166633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Japanese-American female with rapidly progressive interstitial lung disease associated with clinically amyopathic dermatomyositis.
    Takada T; Asakawa K; Barrios R
    Clin Rheumatol; 2021 Mar; 40(3):1159-1165. PubMed ID: 32676922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated carcinoembryonic antigen predicts rapidly progressive interstitial lung disease in clinically amyopathic dermatomyositis.
    Zhu D; Qiao J; Tang S; Pan Y; Li S; Yang C; Fang H
    Rheumatology (Oxford); 2021 Aug; 60(8):3896-3903. PubMed ID: 33398346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum KL-6 level is a prognostic marker in patients with anti-MDA5 antibody-positive dermatomyositis associated with interstitial lung disease.
    Ye Y; Fu Q; Wang R; Guo Q; Bao C
    J Clin Lab Anal; 2019 Oct; 33(8):e22978. PubMed ID: 31301087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.